Novartis CEO predicts future successes due to patent patent From Investing.com

Swiss Pharmariese Novartis AG (SIX:NOVN) has made a one-year sustainable investment in 2028 and is aiming for 2028, a year with an average of 5%. In one of the Samstag-veröffentlicht interviews, he said that CEO Vas Narasimhan had a clairvoyant vision, which sees that he is there rich. After Narasimhan learns that this likely use of the capabilities of eight of his new drugs in an external sportfolio, it is possible that you generate the Milliardenhöhe.

Proud of the protection of patents for any medication, which is responsible for the treatment of pharmaceutical products, Narasimhan bleassen. There is concrete, if the best patent cliffs, which often have great significance in the historical industry, for Novartis the Grund zur Sorge sei. The CEO version assessed the innovative pipeline of the unternehmens and the expected profit and earnings forecast for 2025 by the market position. Narasimhan, since 2018 and the Spitze of Novartis Steht, could become a concrete forecast in January.

Narasimhan said the core subdivisions had a lead of 40.1%. There is a Margin in a 40% investment company when it comes to setting and noticing that the higher Margen in the pharmaceutical industry is not important, that more is invested in Research, Entwicklung and Umsatzwachstum able to to buy.

Darüber is a new attack on the company’s strategic economy, which will strengthen the company’s interests (so-called “Bolt-on-Deals”) in the form of a value of 1 million US dollars. These smaller sizes are so good that it goes very well and becomes stronger. After all, Novartis still has large deals of 10 billion US dollars, but in the historical analysis, the major changes in the pharmaceutical industry are relatively poor results. This Aussage is one of the first results at Fusionen and the vast majority of the flow in the Wachstum with the Lehren from the Branche-fahrungen in Einklang is brought.

Reuters hat zu diesem Artikel beigetragen.

This description can be performed by the intelligent intelligence. Weitere Informationen entnehmen Sie bitte unseren Nutzungsbedingungen.